All posts by Sebastiaan Witkam

Enzyre closes Series A financing round of €12 million

Enzyre, which is developing breakthrough ambulant diagnostic technology for blood coagulation testing, has raised €12 million in a Series A financing led by new investor, Oost NL, with participation from i&i Biotech Fund, Demcon Investment as technology partner and existing investors, Takeda Ventures and Novalis Biotech. Part of the funding is an Innovation Credit from the Dutch Government. The proceeds from the financing will enable Enzyre to further develop its unique diagnostic technology platform, EnzyPad, which will enable hemophilia patients to determine and monitor their coagulation status from home in real-time. Olym advised Enzyre in this funding round.

FlexiDAO closes series A funding round led by SET Ventures

FlexiDAO, a leading software provider for 24/7 electricity and carbon tracking, has secured a $6.5 million investment round led by SET Ventures, with investment from Google and the Microsoft Climate Innovation Fund, and existing investor EIT InnoEnergy. FlexiDAO enables companies and governments to operate on round-the-clock carbon-free energy, by certifying and tracing their electricity and its true carbon content, every hour of every day. We advised lead investor SET Ventures on this series A investment round.

Sale of M&I Broadcast Services to Valsoft Corporation

Valsoft Corporation Inc, a Canadian-based company specializing in the acquisition and development of software businesses, has acquired M&I Broadcast Services, a broadcast services software company that provides appealing, mission-critical software to the industry. M&I has several solutions across several broadcast platforms, including radio automation software OmniPlayer, as well as Nimbus Newsroom for radio, TV and online. M&I software is trusted by prominent European media companies such as RTL, DPG Media, Radio Italia and Talpa. We advised the selling shareholder on this transaction.

Thorizon raises €12.5 million for clean nuclear technology

We advised Thorizon on its 12.5 million euro funding round for the development of a new generation of nuclear power plants. The ‘Thorium molten salt reactor’ developed by Thorizon will use long-lived waste in combination with the abundant metal Thorium as fuel. This makes the reactor capable of making an important contribution to a safe, virtually inexhaustible and CO2-free energy supply. The investors are a strong team of private and public sector parties, including Positron Ventures, Invest-NL, Huisman, PDENH and Impuls Zeeland.